179 related articles for article (PubMed ID: 29162314)
21. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
[No Abstract] [Full Text] [Related]
22. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of squamous histology in bladder cancer: a population-based study.
Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
[TBL] [Abstract][Full Text] [Related]
24. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
25. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.
Nguyen DP; Al Hussein Al Awamlh B; Wu X; O'Malley P; Inoyatov IM; Ayangbesan A; Faltas BM; Christos PJ; Scherr DS
Eur Urol; 2015 Sep; 68(3):399-405. PubMed ID: 25709026
[TBL] [Abstract][Full Text] [Related]
26. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology.
Lin J; Whalen M; Holder D; Hruby G; Decastro GJ; McKiernan J
Can J Urol; 2013 Apr; 20(2):6690-5. PubMed ID: 23587508
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer.
Koehne EL; Bakaloudi DR; Ghali F; Nyame Y; Schade GR; Grivas P; Yezefski TA; Hawley JE; Yu EY; Hsieh AC; Montgomery RB; Psutka SP; Gore JL; Wright JL
Clin Genitourin Cancer; 2024 Jun; 22(3):102100. PubMed ID: 38763862
[TBL] [Abstract][Full Text] [Related]
30. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800
[TBL] [Abstract][Full Text] [Related]
31. The role of radical cystectomy in patients with clinical T4b bladder cancer.
Black PC; Dinney CP; Brown GA; Kassouf W; Siefker-Radtke AO; Munsell MF; Grossman HB; Kamat AM
Urol Oncol; 2011; 29(2):157-61. PubMed ID: 20456984
[TBL] [Abstract][Full Text] [Related]
32. [Clinical outcomes after modified radical cystectomy in the treatment of 188 patients with invasive bladder cancer].
Yu SL; Hou GL; Zhou FJ; Liu ZW; Han H; Qin ZK; Li YH; Zhang ZL; Yao K
Ai Zheng; 2009 May; 28(5):500-5. PubMed ID: 19624878
[TBL] [Abstract][Full Text] [Related]
33. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J
Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
[TBL] [Abstract][Full Text] [Related]
34. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
[TBL] [Abstract][Full Text] [Related]
36. Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.
Kozak KR; Hamidi M; Manning M; Moody JS
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e197-204. PubMed ID: 22401916
[TBL] [Abstract][Full Text] [Related]
37. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
38. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.
Kamat AM; Gee JR; Dinney CP; Grossman HB; Swanson DA; Millikan RE; Detry MA; Robinson TL; Pisters LL
J Urol; 2006 Mar; 175(3 Pt 1):881-5. PubMed ID: 16469571
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Takemoto K; Teishima J; Kohada Y; Ikeda K; Nagamatsu H; Goriki A; Inoue S; Hayashi T; Kajiwara M; Matsubara A
Anticancer Res; 2020 Aug; 40(8):4787-4793. PubMed ID: 32727806
[TBL] [Abstract][Full Text] [Related]
40. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
